[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100384663":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":33,"responsibleParty":52,"collaborators":10,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":67,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":73,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University Hospital, Angers","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Septic shock admitted in Angers' ICU",null,"Patients aged more than 18, admitted in University Hospital of Angers, who meet the full criteria of septic shock",[13],"Biological: Whole blood samples",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"BIOLOGICAL","Whole blood samples","Whole blood samples at admission, from day one to three after admission",[9],[21],{"name":22,"affiliation":23,"role":24},"Julien DEMISELLE, MD","University Hospital of Angers","PRINCIPAL_INVESTIGATOR",[26,30],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","+33 2 41 35 58 65","Julien.Demiselle@chu-angers.fr",{"name":31,"role":27,"phone":28,"phoneExt":10,"email":32},"Pierre ASFAR, MD PhD","PiAsfar@chu-angers.fr",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"CHU","RECRUITING","Angers","Maine et Loire","49933","France","FR",{"type":43,"coordinates":44},"Point",[45,46],-0.55202,47.47156,{"lat":46,"lon":45},[49],{"name":50,"role":27,"phone":51,"phoneExt":10,"email":32},"ASFAR Pierre, MD-PhD","00332355865",{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100384663","impact-of-metabolite-supplementation-to-restore-mitochondrial-dysfunction-during-septic-shock-a-preclinical-study-100384663",false,"NCT04288635","Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study","Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study: MEFDASE Study","MEFDASE","Inclusion Criteria:\n\n* All patients aged 18 or more\n* Patients with criteria for septic shock according to SEPSIS 3 definition (presumed sepsis, with persisting hypotension requiring vasopressors to maintain mean arterial pressure \\> 65 mmHg and having a serum lactate \\> 2 mmol\u002FL despite adequate fluid expansion).\n* Admitted in the ICU of Angers University Hospital\n\nExclusion Criteria:\n\n* Minor patients (aged less 18)\n* Patient subject to legal protection measures\n* Refusal of the patient or his family\n* Preexisting mitochondrial disease\n* Patient with aplasia\n* Pregnant or parturient women","ALL","18 Years",{"count":65,"type":66},55,"ESTIMATED","28 Days","OBSERVATIONAL","Septic shock is defined as a subset of sepsis with severe metabolism alterations, leading to organ failure. Septic shock is associated with a high mortality, around 40% according to the SEPSIS 3 definition.\n\nMetabolic alterations are responsible for lactic acidosis, and results in mitochondrial dysfunction.\n\nThis study aims at evaluate the impact of exogenous metabolites on restoring mitochondrial function in septic shock patients with lactate acidosis.\n\nMitochondrial metabolism (quantitative analysis, mitochondrial function) in intact Peripheral Blood Mononuclear Cells (PBMC) will be isolate and analyse from patients at the early phase of septic shock (admission), at day 2 and 4. Participant's medical history will be recorded: renal and liver metabolism, severity scores and outcomes and the need for supportive care in the intensive care unit (ICU) until 28 days after admission.\n\nFurthermore, the investigators will evaluate wether selected metabolites added to the cell culture medium may improve mitochondrial metabolism.",[71,72],"Septic Shock","Multiple Organ Failure",[74],"mitochondrial dysfunction","2025-12-02",{"date":77,"type":78},"2025-12-08","ACTUAL",{"date":80,"type":78},"2020-07-09",{"date":82,"type":66},"2026-08-09",{"name":5,"class":6},1]